What Is Fractional Shortening (FS) on an Echocardiogram?

Fractional shortening is a quick echocardiographic measurement that estimates how well the left ventricle squeezes during each heartbeat. It compares the size of the left ventricle when it is relaxed and full of blood to its size at peak contraction, expressing the difference as a percentage. A normal value generally falls in the range of about 25 to 45 percent, with numbers below that range suggesting the heart muscle is not contracting forcefully enough. The measurement is one of the oldest and simplest ways to gauge systolic function, and while it remains widely used, its limitations have become clearer as more sophisticated imaging tools have emerged.

How the Measurement Works

During an echocardiogram, the sonographer places a cursor line across the left ventricle in what is called M-mode, a technique that records motion along a single beam over time. Two key dimensions are captured: the internal diameter of the left ventricle at the end of diastole (when the chamber is full) and at the end of systole (when the chamber has squeezed down). Fractional shortening is then the difference between those two diameters, divided by the diastolic diameter, multiplied by 100 to give a percentage. If your left ventricle measures 5 cm when relaxed and 3 cm at peak contraction, for example, your FS would be 40 percent.

This calculation is appealing because it takes only seconds and requires minimal technology. A two-dimensional image frozen in M-mode is enough. There is no need for tracing the entire chamber border, no volume modeling, and no contrast injection. That simplicity is why FS became a bedside staple in cardiology and why it persists even in settings where ejection fraction has become the headline number most patients hear about.

What Your FS Number Means

An FS in the ballpark of 25 to 45 percent is considered normal for most adults. Below about 25 percent generally signals reduced systolic function, meaning the heart muscle is not shortening enough to pump blood effectively. An FS below roughly 20 percent typically points to more severe impairment and may accompany clinical heart failure symptoms like fatigue, fluid retention, and shortness of breath.

On the other end, an unusually high FS can occur in conditions where the heart is contracting more vigorously than normal, sometimes called a hyperdynamic state. Severe anemia, thyrotoxicosis, significant mitral regurgitation, and hypertrophic cardiomyopathy can all push FS above the normal range. In hypertrophic cardiomyopathy, for instance, the pathophysiology involves a hyper-contractile left ventricle alongside diastolic dysfunction and potential obstruction, all coexisting in the same patient.¹ A high FS in that context does not mean the heart is healthy; it means the muscle is thickened and overactive in ways that create their own problems.

The Load Dependence Problem

The biggest weakness of fractional shortening is that it does not purely reflect the heart muscle’s intrinsic contractile strength. It is sensitive to loading conditions, meaning the amount of blood filling the heart before contraction (preload) and the resistance the heart pumps against (afterload) both change the number independently of how strong the muscle actually is.

Classic research demonstrated this clearly. When preload was increased by expanding blood volume in study subjects, fractional shortening changed even though the heart’s underlying contractility had not. Acute increases in afterload, achieved by raising blood pressure with a vasopressor, led to a substantial drop in the velocity of fiber shortening, with one study showing roughly a 38 percent decrease when peak wall stress rose by about 44 percent.² The relationship between wall stress and fractional shortening turned out to be dependent on how stretched the muscle fibers were at end-diastole, further confirming that FS is not a clean window into contractility alone.³

In practical terms, this means a patient who is dehydrated or has low blood volume might show a lower FS that improves after receiving fluids, without any change in the muscle itself. Conversely, someone with severe high blood pressure might show a depressed FS that rebounds once the pressure is treated. If your doctor sees an unexpectedly low or high FS, the first question is often whether something about the loading conditions explains the number before concluding the heart muscle is in trouble.

How FS Relates to Ejection Fraction

Ejection fraction (EF) is the more commonly quoted number in cardiology today. While FS measures the change in diameter along a single line, EF estimates the percentage of blood volume ejected from the ventricle with each beat. EF uses two-dimensional or three-dimensional images to trace the full chamber outline, making it a more comprehensive assessment. In a geometrically normal, roughly elliptical ventricle, FS and EF tend to track each other closely. Mathematical models can convert one to the other, and in dogs, for example, FS proved to be a robust indicator of EF with high sensitivity and specificity for detecting decreased systolic function.⁴

The relationship breaks down, however, when the left ventricle is not shaped normally. A ventricle with a large wall motion abnormality from a heart attack, for instance, might contract well in one area (the segment the M-mode cursor happens to cross) and barely at all in another. FS measured from that single line could look reassuringly normal while EF, which accounts for the whole chamber, shows significant impairment. This is one reason EF has largely overtaken FS as the primary metric in clinical decision-making, particularly when guiding device therapy or determining eligibility for heart failure medications.

When FS Misses the Real Story in Thick Hearts

One of the more subtle pitfalls of fractional shortening involves patients with left ventricular hypertrophy from longstanding high blood pressure. Research has consistently shown that these patients can have a perfectly normal endocardial FS and a normal ejection fraction while the muscle fibers deeper in the wall, at the midwall level, are actually contracting less than they should.

A landmark study found that endocardial fractional shortening and ejection fraction did not differ between hypertensive patients with thickened hearts and healthy controls, but midwall fractional shortening was significantly depressed in the hypertrophy group.⁵ In six out of seven patients with hypertrophy, midwall stress-shortening coordinates fell outside the normal confidence limits, even though standard FS looked fine. Later work confirmed that this midwall depression improved when blood pressure control led to regression of the thickened walls.⁶

The geometry of a thick-walled ventricle explains part of the disconnect. When walls are thicker, the inner surface (endocardium) moves inward more during contraction due to the sheer volume of muscle behind it, inflating the standard FS measurement. Meanwhile, the midwall fibers doing most of the work may be struggling. Additional research suggested that geometric factors are a major determinant of this apparent discrepancy, though in hypertensive patients specifically, there also appears to be a true impairment in how the muscle responds to increasing wall stress.⁷ For anyone with longstanding hypertension and a “normal” FS, the number can provide false reassurance.

Challenges in Children and Newborns

FS is frequently measured in pediatric echocardiography, but its limitations loom even larger in young patients. Children with congenital heart disease often have abnormal loading conditions from birth. Shunts, valve abnormalities, and altered circulation all shift preload and afterload in ways that make FS an unreliable marker of how well the muscle itself is working. Expert guidance has noted that while FS is among the most commonly used pump indices in congenital heart disease, it may produce invalid data precisely because of this load dependence.⁸

The problem was demonstrated starkly in a study of HIV-infected infants and children, a population known to have abnormal preload and afterload. When researchers compared FS to more direct assessments of contractility in 177 echocardiograms from 76 patients, FS incorrectly predicted contractility in 46 percent of the studies. Among those with a depressed FS below 28 percent, 43 percent actually had normal or even enhanced contractility when measured with load-independent methods.⁹ Nearly half the time, the simple FS number was telling the wrong story.

Even in premature newborns without complex heart disease, FS has shown only moderate reliability. A study of extremely preterm infants found that the intraclass correlation coefficient for FS was about 0.72 for M-mode and 0.73 for two-dimensional mode, meaning that repeat measurements on the same infant could vary enough to change clinical interpretation.¹⁰ The authors cautioned against relying on FS alone when evaluating left ventricular function in this fragile population.

Monitoring Heart Damage From Chemotherapy

Anthracycline chemotherapy drugs, used widely in cancers like leukemia and breast cancer, carry a well-known risk of damaging the heart. Cardiologists have traditionally tracked FS and ejection fraction during and after treatment to catch early signs of toxicity. In practice, FS and EF have been the most widely used parameters for this purpose, but FS in particular has proven less reliable for early detection of damage that has not yet caused symptoms.¹¹ Because both FS and EF depend on loading conditions, they can appear normal even when subclinical injury is underway. By the time FS drops noticeably, irreversible damage may already have occurred. This has driven a shift toward newer techniques like global longitudinal strain for surveillance in oncology patients.

What FS Can Tell You About Prognosis

Despite its limitations as a contractility index, FS does carry prognostic weight. In the general population, lower FS is associated with a higher risk of sudden cardiac death. A large population-based study found that each standard deviation decrease in left ventricular FS was linked to a roughly 36 percent increase in the hazard of sudden cardiac death.¹² That is a meaningful signal, especially given that the measurement takes seconds to obtain.

In patients already diagnosed with heart failure, FS has also been identified as one of the parameters that differed between those who survived follow-up and those who did not. Non-survivors had a mean FS of about 17 percent compared to roughly 20 percent in survivors.¹³ While EF also differed between these groups, the directional agreement reinforces that FS, for all its imperfections, captures something real about cardiac risk.

FS has been applied to the right ventricle as well, though less commonly. Fractional shortening of the right ventricular outflow tract proved to be an independent predictor of adverse events in patients with left ventricular dysfunction. Those with a right ventricular outflow tract FS of 0.2 or above had significantly better event-free survival over a median follow-up of about 319 days.¹⁴ A separate validation study showed that various right ventricular FS indices correlated with cardiac MRI-derived right ventricular ejection fraction at levels comparable to the more commonly used fractional area change method.¹⁵

When Strain Imaging Does a Better Job

One of the clearest demonstrations of FS’s blind spots comes from neonatal research. In a study of term newborns who had experienced birth asphyxia, FS was virtually identical between the asphyxiated group and healthy controls, at about 29 percent in both. The FS measurement completely missed the myocardial injury. Strain and strain rate imaging by tissue Doppler, however, detected significant differences between the groups, proving more sensitive for identifying reduced function in this setting.¹⁶

Strain imaging measures actual deformation of the muscle in multiple directions, not just the inward motion of the endocardial surface along one line. It can detect subtle abnormalities in how the muscle lengthens, shortens, and twists, making it far more sensitive to early damage. This is particularly relevant in the chemotherapy monitoring scenario described earlier, where catching subclinical injury before FS drops is the whole point of surveillance.

The trade-off is complexity. Strain measurements require higher-quality images, specialized software, and more expertise to perform and interpret. They also take longer. FS will never fully disappear from clinical practice precisely because of its speed and simplicity, but its role is gradually shifting from a standalone assessment to one piece of a broader evaluation.

Automation and the Future of Quick Measurements

Deep learning algorithms are already being tested to automate echocardiographic measurements in real time, reducing the variability that comes from having different sonographers eyeball the same images. A recent study found that an automated deep-learning tool could measure left ventricular volumes and ejection fraction with small biases compared to manual measurements, though it tended to produce slightly lower EF values.¹⁷ These tools can also guide less experienced operators to obtain better images in the first place, which addresses one of the practical sources of FS measurement error.

Most of the current AI development has focused on volumetric EF and global longitudinal strain rather than FS specifically, which reflects the broader clinical trend. But because FS is derived from simple diameter measurements, it is arguably easier to automate than the more complex tracings needed for EF. Whether automation revives interest in FS by making it more reproducible, or whether the clinical world simply leapfrogs to strain-based metrics that AI handles equally well, remains to be seen.

FS in Veterinary Cardiology

Fractional shortening remains a workhorse measurement in veterinary medicine, particularly for dogs and cats. In veterinary echocardiography, the smaller heart sizes and faster heart rates of animal patients make M-mode-derived FS especially practical. A large study evaluating the relationship between FS and EF in dogs found that FS had a sensitivity of 92 percent and specificity of 93 percent for detecting low ejection fraction from the standard right parasternal view, with a negative predictive value of 99 percent.⁴ That high negative predictive value means a normal FS in a dog is extremely reliable for ruling out significant systolic dysfunction.

Normal FS ranges differ by species and breed. Large-breed dogs tend to have lower FS values than small breeds, and feline hearts operate at different baselines than canine ones. The principles and pitfalls carry over from human medicine: a dog with abnormal loading conditions from severe mitral valve disease may have an artificially elevated FS that masks underlying muscle deterioration. Veterinary cardiologists increasingly use FS alongside other measurements rather than in isolation, much like their counterparts in human medicine. In animal research, FS continues to serve as a primary endpoint for cardiac studies. Work in mouse models of cardiomyopathy, for instance, has shown strong correlations between FS-derived function indices and post-mortem findings of heart failure.¹⁸